Experienced in Ulcerative Colitis

Dr. Prateek D. Wali

Pediatric Gastroenterology | Pediatrics
725 Irving Ave, Crouse POB Ste 805, 
Syracuse, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Ulcerative Colitis
725 Irving Ave, Crouse POB Ste 805, 
Syracuse, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Prateek Wali is a Pediatric Gastroenterologist and a Pediatrics provider in Syracuse, New York. Dr. Wali is rated as an Experienced provider by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Viral Gastroenteritis, Hemorrhagic Proctocolitis, Ulcerative Colitis, and Colitis.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Ulcerative Colitis.

Specialties
Pediatric Gastroenterology
Pediatrics
Licenses
Pediatrics in AR
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

725 Irving Ave, Crouse POB Ste 805, Syracuse, NY 13210
Other Locations
1 Childrens Way # 512, Little Rock, AR 72202

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Recruiting
Publish Date: October 20, 2025
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Pragmatic Clinical Trial To Evaluate The Effectiveness Of Low Dose Oral Methotrexate In Patients With Pediatric Crohn's Disease Initiating Anti-TNF Therapy
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Other, Drug
Study Drugs: Methotrexate, Ondansetron
Study Phase: Phase 3
View 2 Less Clinical Trial

13 Total Publications

Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: June 12, 2024
Similar Doctors
Experienced in Ulcerative Colitis
Dr. Cassandra A. Archer
Pediatrics | Internal Medicine
Experienced in Ulcerative Colitis
Dr. Cassandra A. Archer
Pediatrics | Internal Medicine
161 Genesee St, Suite 203, 
Auburn, NY 
 (23.2 miles away)
315-255-0947
Languages Spoken:
English
See accepted insurances

Cassandra Archer is a primary care provider, practicing in Pediatrics and Internal Medicine in Auburn, New York. Dr. Archer is rated as an Advanced provider by MediFind in the treatment of Ulcerative Colitis. Her top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and Localized Scleroderma.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wali's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile